DSGN icon

Design Therapeutics

83 hedge funds and large institutions have $413M invested in Design Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.82M
Puts
$1.24M
Net Calls
Net Calls Change

Top Buyers

1 +$21.8M
2 +$9.23M
3 +$3.85M
4
Bank of America
Bank of America
North Carolina
+$2.35M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$2.18M

Top Sellers

1 -$19.5M
2 -$16.8M
3 -$7.64M
4
Goldman Sachs
Goldman Sachs
New York
-$7.38M
5
TCM
Tekla Capital Management
Massachusetts
-$4.69M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$67M
2
$52.8M
3
$36M
4
$31.2M
5
$30.5M
6
$28.7M
7
$25.7M
8
$23.3M
9
$16M
10
$11.5M
11
$11.3M
12
$9.08M
13
$8.03M
14
$7.62M
15
$7.1M
16
$6.19M
17
$5.3M
18
$4.72M
19
$3.04M
20
$2.86M
21
$2.82M
22
$2.5M
23
$2.37M
24
$1.6M
25
$1.34M